Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/17 → 7/31/18 |
Sorafenib抗藥性所誘發之肝癌惡病質與癌幹細胞特性之細胞療法：利用全身安全性之人類胎盤蛻膜間葉幹細胞標靶TNFα-IL6之免疫調控與攜帶奈米藥物對抗Sorafenib抗藥性肝癌之雙功能策略(先期補助)
- Huang, Yen-Hua (PI)
- Department of Biochemistry and Molecular Cell Biology
- TMU Research Center of Cancer Translational Medicine
- International Master Program in Medicine
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- TMU Research Center of Thoracic Medicine
- TMU Research Center of Cell Therapy and Regeneration Medicine
Project: A - Government Institution › f - Other (Funded by Government)